Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Core Viewpoint - Eyenovia plans to submit for U.S. regulatory approval of its Optejet device in Q4 2025, which is a significant step towards commercialization [1][2] Company Overview - Eyenovia, Inc. is an ophthalmic technology company focused on developing the Optejet topical ophthalmic medication dispensing platform [6] Product Development - The Optejet is designed to address common issues with traditional eye drops, such as inaccurate administration and discomfort, potentially tapping into multi-billion-dollar ophthalmic markets [2][5] - The user-filled Optejet features a sterile disposable cartridge that users can fill with their own eyedropper bottle, capable of dispensing up to 180 metered sprays [3] - The device has undergone rigorous testing, showing that 98% of sprays are between 8-9 microliters, which aligns with the eye's capacity [4] Market Potential - The user-filled Optejet is expected to be compatible with various topical ophthalmic liquids, with projected sales of $4 billion in the U.S. for these products in the current year [5]